Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Reviews in Urology
|
September 21, 2006
Surveillance strategies for renal cell carcinoma patients following nephrectomy
Arnold I Chin, John S Lam, Robert A Figlin, et al.
Nature
|
March 15, 2002
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses
Arnold I Chin, Paul W Dempsey, Kevin Bruhn, et al.
The Journal of Urology
|
March 10, 2015
Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
David R Li, Hanwei Zhang, Elizabeth Peek, et al.
Case Reports in Urology
|
February 8, 2022
Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
Zhiyu Qian, Emily Chou, Jing Yang, et al.
Cancer Research
|
March 18, 2010
Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance
Arnold I Chin, Andrea K Miyahira, Anthony Covarrubias, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 16, 2010
Immunological therapy in urological malignancy: novel combination strategies
David S Finley, Frederic Pouliot, Arnold I Chin, et al.
Cancer Research Communications
|
August 5, 2024
Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Hanwei Zhang, Ann Ly, Emily Chou, et al.
American Journal of Cancer Research
|
December 11, 2012
Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model
Elizabeth M Peek, David R Li, Hanwei Zhang, et al.
Urology Practice
|
August 18, 2023
Development and Validation of an Automated Method to Identify Patients Undergoing Radical Cystectomy for Bladder Cancer Using Natural Language Processing
Hung-Jui Tan, Robin Clarke, Karim Chamie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2016
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance
Hanwei Zhang, Kris Prado, Kelvin X Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Reviews in Urology
|
September 21, 2006
Surveillance strategies for renal cell carcinoma patients following nephrectomy
Arnold I Chin, John S Lam, Robert A Figlin, et al.
Nature
|
March 15, 2002
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses
Arnold I Chin, Paul W Dempsey, Kevin Bruhn, et al.
The Journal of Urology
|
March 10, 2015
Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
David R Li, Hanwei Zhang, Elizabeth Peek, et al.
Case Reports in Urology
|
February 8, 2022
Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
Zhiyu Qian, Emily Chou, Jing Yang, et al.
Cancer Research
|
March 18, 2010
Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance
Arnold I Chin, Andrea K Miyahira, Anthony Covarrubias, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 16, 2010
Immunological therapy in urological malignancy: novel combination strategies
David S Finley, Frederic Pouliot, Arnold I Chin, et al.
Cancer Research Communications
|
August 5, 2024
Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Hanwei Zhang, Ann Ly, Emily Chou, et al.
American Journal of Cancer Research
|
December 11, 2012
Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model
Elizabeth M Peek, David R Li, Hanwei Zhang, et al.
Urology Practice
|
August 18, 2023
Development and Validation of an Automated Method to Identify Patients Undergoing Radical Cystectomy for Bladder Cancer Using Natural Language Processing
Hung-Jui Tan, Robin Clarke, Karim Chamie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2016
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance
Hanwei Zhang, Kris Prado, Kelvin X Zhang, et al.
Page
of 3